Roche Molecular Systems Software Engineering Manager Salaries in San Francisco
The average Roche Molecular Systems Software Engineering Manager in San Francisco earns an estimated $204,737 annually, which includes an estimated base salary of $165,880 with a $38,857 bonus. Roche Molecular Systems' Software Engineering Manager compensation is $45,161 more than the US average for a Software Engineering Manager. Software Engineering Manager salaries at Roche Molecular Systems in San Francisco can range from $104,000 - $372,500.
In San Francisco, The Engineering Department at Roche Molecular Systems earns $3,426 more on average than the Legal Department.
Last updated a year ago.
- $165,880
- avg. base
- $38,857
- avg. bonus
Software Engineering Manager Salaries at Roche Molecular Systems
In San Francisco, Software Engineering Managers earn $2,851 more than Engineering Managers, and $11,480 less than Group Engineering Managers.
Compensation at Roche Molecular Systems by Department
In San Francisco, The Engineering Department averages $3,426 more than the Legal Department, and $14,963 less than the Product Department
Software Engineering Manager Compensation by Gender (All Companies)
The average female Software Engineering Manager at companies similar size to Roche Molecular Systems reported making $164,584, while the average male Software Engineering Manager at similar sized companies reported making $184,820.
Software Engineering Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Software Engineering Manager at companies similar size to Roche Molecular Systems reported making $191,271, while the average Native American Software Engineering Manager at similar sized companies reported making $155,000.
How Software Engineering Managers at Roche Molecular Systems Rate Their Compensation
The majority of Software Engineering Managers at Roche Molecular Systems believe they're compensated fairly. 100% of Software Engineering Managers at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
